1. Home
  2. SAVA vs OGI Comparison

SAVA vs OGI Comparison

Compare SAVA & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.08

Market Cap

156.5M

Sector

Health Care

ML Signal

HOLD

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

HOLD

Current Price

$1.73

Market Cap

218.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAVA
OGI
Founded
1998
2013
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
156.5M
218.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SAVA
OGI
Price
$2.08
$1.73
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
1.0M
1.8M
Earning Date
11-12-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$186,075,713.00
Revenue This Year
N/A
$20.38
Revenue Next Year
N/A
$6.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$0.85
52 Week High
$4.98
$2.24

Technical Indicators

Market Signals
Indicator
SAVA
OGI
Relative Strength Index (RSI) 34.23 48.54
Support Level $1.96 $1.67
Resistance Level $3.32 $1.86
Average True Range (ATR) 0.18 0.18
MACD -0.06 -0.03
Stochastic Oscillator 9.27 31.33

Price Performance

Historical Comparison
SAVA
OGI

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Share on Social Networks: